| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V3047 | A 10255 | 144376-84-1 | A 10255 (also names as A10255, A-10255) is a macrolide type of complex and a thiopeptide antibiotics that is isolated from Streptomyces gardneri. |
|
V3053 | A-119637 | 255713-47-4 | A-119637 is a novel, selective and potent antagonist of the alpha1D adrenoceptor. |
|
V3056 | A-123189 | 255713-53-2 | A-123189 is a novel, selective and potent α1Dantagonists in both the α1clonal cell lines and in in vitro tissue strips. |
|
V3058 | A-130C | 73522-76-6 | A-130C is a novel and potent polyether antibiotic originally isolated from the metabolites of strepto,yces hygroscopicus by a Japanese research group in 1980. |
|
V3066 | A-192621 | 195529-54-5 | A-192621 is an antagonist of endothelin-B. |
|
V3089 | A-315675 | 335679-69-1 | A-315675,a pyrrolidine-based compound, is a novel and potent anti-infuenza agent. |
|
V3050 | A110 | 1185388-35-5 | A110 is a novel, potent and selective inhibitor of IMPDHs. |
|
V3074 | A23887 | 61955-05-3 | A23887(A 23887 or A-23887)is atetracyclic spiro aminewhich has previously been shown to have considerable affinity for dopamine D-2 receptors. |
|
V3742 | ABT-639 HCl | 1235560-31-2 | ABT-639hydrochloride (HCl) is a new potent, peripherally acting, selective T-type Ca2+channel blocker that blocks recombinant human T-type (Cav3.2) Ca2+channels in a voltage-dependent fashion (IC50=2 μM) and attenuates low voltage-activated (LVA) currents in rat DRG neurons (IC50=8 μM). |
|
V0433 | ALG1001 TFA | 1307293-62-4 | ALG1001 has been discontinued due to commercial reasons. |
|
V3814 | Atabecestat HCl (JNJ-54861911) | 1200493-78-2 | Atabecestat HCl (formerly known as JNJ-54861911 HCl), the hydrochloride salt ofAtabecestat, is a novel potent, oral, and brain-penetrantinhibitor of β-site amyloid precursor protein cleaving enzyme 1 (BACE1), which is an enzyme that is up-regulated in Alzheimer's disease. |
|
V4253 | AZD9056 | 345304-65-6 | AZD9056 is a novel, potent, selective, orally bioavailable antagonist of P2X7 receptor which is an adenosine triphosphate (ATP)-gated cation channel expressed on a variety of cell types believed to play a role in inflammation. |
|
V2060 | BMS 433796 | 935525-13-6 | BMS 433796 is a novel and potentγ-secretaseinhibitor withAβlowering activity in a transgenic mouse model of Alzheimers disease. |
|
V2110 | BMS-751324 | 948842-66-8 | BMS-751324 is a novel prodrug of BMS-582949 (also known as PS540446) which is a potent and highly selective p38 mitogen-activated protein kinase (p38 MAPK) inhibitor with IC50 of 13nM and is currently in phase II clinical trials for the treatment of rheumatoid arthritis. |
|
V3465 | BMS-986169 | 1801151-08-5 | BMS-986169 is a novel and potent negative allosteric modulator ofGluN2B which is aN-methyl-d-aspartate receptor subtype. |
|
V3498 | BPN14770 | 1606975-12-5 | BPN14770 is a novel and potent allosteric modulator of phosphodiesterase-4 (PDE4) with IC50 values of 8 and 130 nM for human and mouse PDE4D, respectively. |
|
V2130 | GNE-5729 | 2026635-66-3 | GNE 5729 is a novel, potent, brain permeable positive allosteric modulator (PAM) and GluN2A subunit-selective ofNMDAR with anEC50of 37 nM for GluN2A, 4.7 and 9.5 μM for GluN2C and GluN2D, respectively. |
|
V3617 | GSK3395879 | 2215852-91-6 | GSK3395879 is a novel, potent, selective and orally bioavailable transient receptor potential vanilloid-4 (TRPV4) antagonist with anIC50of 1 nM for hTRPV4. |
|
V3546 | KD-3010 | 934760-90-4 | KD-3010 is a potent, orally bioactive, and selective agonist of peroxisome proliferator-activated receptordelta(PPARδ)that can be potentially used for the treatment of diabetes and obesity. |
|
V4102 | KT5823 | 126643-37-6 | KT5823 (KT-5823),a staurosporine-related analog,is a selective inhibitor of protein kinase G (PKG) with anticancer activity. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
